Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.

Japanese journal of clinical oncology - 9 Mar 2020

Zhao Zhenyu, Zhang Cheng, Li Mi, Shen Yiping, Feng Shiyu, Liu Jialin, Li Fangye, Hou Lei, Chen Zhong, Jiang Jingjing, Ma Xiaodong, Chen Ling, Yu Xinguang

Abstract excerpt

OBJECTIVE: The 2016 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) was revised to include molecular biomarkers as diagnostic criteria. However, conventional biopsies of gliomas were spatially and temporally limited. This study aimed to determine whether circulating tumor DNA (ctDNA) from cerebrospinal fluid (CSF) could provide more comprehensive diagnostic information...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Glioma

Share to Neoplasm Recurrence, Local

Share to PTEN Phosphohydrolase

Share to Retinoblastoma Binding Proteins

Share to Ubiquitin-Protein Ligases

Source

Identifiers

PMID: 32039443
DOI: 10.1093/jjco/hyz156

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applications of cerebrospinal fluid circulating tumor DNA in the diagnosis of gliomas.PMID 32039443Read ↗

Circulating Tumor DNA in Adults With Glioma: A Systematic Review and Meta-Analysis of Biomarker Performance.Semantic proximity Read ↗

Cerebrospinal fluid-derived genomic alterations tracking gliomaSemantic proximity Read ↗

Application of Circulating Tumor DNA in the Auxiliary Diagnosis and Prognosis Prediction of GliomaSemantic proximity Read ↗

CSF ctDNA analysis guides molecular reclassification of diffuse glioma patients.Semantic proximity Read ↗

Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients.Semantic proximity Read ↗

The emerging role of circulating tumor DNA in brain tumor researchSemantic proximity Read ↗

Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?Semantic proximity Read ↗

Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation.Semantic proximity Read ↗

Cerebrospinal Fluid ctDNA-Based Molecular Assessment of Resection Extent and Prognosis in GliomaSemantic proximity Read ↗

Tapping into the genome: the role of CSF ctDNA liquid biopsy in gliomaSemantic proximity Read ↗

Evaluating the clinical utility of genomic profiling using cerebrospinal fluid to inform treatment and management of central nervous system tumors – a Meta Analysis of the literatureSemantic proximity Read ↗

Usefulness of circulating tumor DNA from cerebrospinal fluid in recurrent high-grade glioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.